NCT04119024 2026-03-17
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Phase 1 Recruiting
Clinical Trials
63 trialsNCT07092514 2026-03-17
Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)
Washington University School of Medicine
Phase 2 Recruiting
NCT04927416 2026-03-13
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT05538130 2026-03-04
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Pfizer
Phase 1 Recruiting
NCT07447089 2026-03-04
EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study
Università Cattolica di Milano
Phase NA Recruiting
NCT05108298 2026-03-02
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Eastern Cooperative Oncology Group
Phase NA Recruiting
NCT06554652 2026-02-27
Selective Neck Dissection Versus Modified Neck Dissection in PTC
Fudan University
Phase 3 Recruiting
NCT06558981 2026-02-27
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
Fudan University
Phase 3 Recruiting
NCT07436455 2026-02-27
NISDETECT
Ankara University
Phase NA Recruiting
NCT07438847 2026-02-27
177Lu-CTR-FAPI for the Treatment of Thyroid Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1 Recruiting
NCT07433283 2026-02-25
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Sichuan Enray Pharmaceutical Sciences Company
Phase 1/2 Recruiting
NCT05229341 2026-02-23
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
City of Hope Medical Center
Phase NA Recruiting
NCT06007924 2026-02-19
A Study of Avutometinib and Defactinib in People With Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07023731 2026-02-19
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Arvinas Inc.
Phase 1/2 Recruiting
NCT04104529 2026-02-05
BCB RIV
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Recruiting
NCT04916990 2026-02-05
Improving Care for Rural Patients With Solid Tumors
University of Colorado, Denver
Phase NA Recruiting
NCT05355701 2026-02-03
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Pfizer
Phase 1 Recruiting
NCT06984991 2026-02-03
FNA inadequacy
Assiut University
Phase NA Recruiting
NCT07370675 2026-01-27
Active Surveillance for Bethesda IV Thyroid Nodules
Rigshospitalet, Denmark
Phase NA Recruiting
NCT06771219 2026-01-23
SLV-154 Treatment of Metastatic Solid Tumors
Solve Therapeutics
Phase 1 Recruiting
NCT06853925 2026-01-16
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
Georgetown University
Phase NA Recruiting
NCT06980103 2026-01-08
Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer
Georgetown University
Phase NA Recruiting
NCT06961084 2026-01-07
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
University of California, San Francisco
Phase 2 Recruiting
NCT06860971 2025-12-31
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Recruiting
NCT03647358 2025-12-02
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT06458036 2025-11-25
RAISE
Children's Hospital of Philadelphia
Phase 2 Recruiting
NCT04589624 2025-11-21
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT06959511 2025-11-19
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT07235566 2025-11-19
MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC
Fudan University
Phase 2 Recruiting
NCT05783323 2025-11-14
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Children's Hospital of Philadelphia
Phase 2 Recruiting
NCT06902376 2025-11-05
NEO-COMBATXL
UNC Lineberger Comprehensive Cancer Center
Phase 1 Recruiting
NCT05999630 2025-10-28
Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
Vanderbilt University Medical Center
Phase 3 Recruiting
NCT04693377 2025-10-27
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT03517579 2025-10-15
Personalized Treatment in Thyroid Disorders
Johns Hopkins University
Phase NA Recruiting
NCT04290663 2025-10-14
INTERMEDIATE
Centre Francois Baclesse
Phase 3 Recruiting
NCT06222606 2025-10-06
Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism
Aarhus University Hospital
Phase NA Recruiting
NCT06455371 2025-09-10
Patient-centered Dosage of Levothyroxine
University Hospital of North Norway
Phase NA Recruiting
NCT02609685 2025-09-09
PMCAS
Cedars-Sinai Medical Center
Phase NA Recruiting
NCT06220656 2025-08-26
TRAIL Study: Feasibility and Pilot
Dartmouth-Hitchcock Medical Center
Phase NA Recruiting
NCT07118176 2025-08-12
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
Phase 1 Recruiting
NCT06923826 2025-07-25
TROP2
National University Hospital, Singapore
Phase 2 Recruiting
NCT03093116 2025-07-10
TRIDENT-1
Turning Point Therapeutics, Inc.
Phase 1/2 Recruiting
NCT07033572 2025-07-03
Hybrid Endoscopic Hemithyroidectomy and Targeted Ablation for Bilateral Papillary Thyroid Carcinoma
Fujian Medical University
Phase NA Recruiting
NCT04892303 2025-07-01
Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Recruiting
NCT03175224 2025-06-27
SPARTA
Apollomics Inc.
Phase 2 Recruiting
NCT06239194 2025-06-22
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
ModeX Therapeutics, An OPKO Health Company
Phase 1/2 Recruiting
NCT06673329 2025-05-14
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
Phase 1 Recruiting
NCT06929650 2025-04-16
The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
University Health Network, Toronto
Phase NA Recruiting
NCT06898437 2025-04-15
Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Recruiting
NCT06918223 2025-04-13
TISCAV
Thomas Jefferson University
Phase NA Recruiting